Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd has announced the issuance of 2,000,000 unquoted equity securities in the form of options, expiring on June 6, 2027, with an exercise price of $0.555. This issuance is part of previously announced transactions and is not intended to be quoted on the ASX, potentially impacting the company’s financial strategy and stakeholder interests by expanding its equity base.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.43 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves the large-scale study of proteins, particularly their structures and functions, with a market focus on diagnostic solutions.
Average Trading Volume: 147,943
Technical Sentiment Signal: Sell
Current Market Cap: A$56.73M
Find detailed analytics on PIQ stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue